ADMA
Price
$16.41
Change
-$0.46 (-2.73%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
4.03B
58 days until earnings call
NAGE
Price
$9.44
Change
+$0.03 (+0.32%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
750.48M
51 days until earnings call
Interact to see
Advertisement

ADMA vs NAGE

Header iconADMA vs NAGE Comparison
Open Charts ADMA vs NAGEBanner chart's image
ADMA Biologics
Price$16.41
Change-$0.46 (-2.73%)
Volume$132.44K
Capitalization4.03B
Niagen Bioscience
Price$9.44
Change+$0.03 (+0.32%)
Volume$10.19K
Capitalization750.48M
ADMA vs NAGE Comparison Chart in %
Loading...
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADMA vs. NAGE commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADMA is a Hold and NAGE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (ADMA: $16.87 vs. NAGE: $9.41)
Brand notoriety: ADMA and NAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADMA: 93% vs. NAGE: 64%
Market capitalization -- ADMA: $4.03B vs. NAGE: $750.48M
ADMA [@Biotechnology] is valued at $4.03B. NAGE’s [@Biotechnology] market capitalization is $750.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADMA’s FA Score shows that 2 FA rating(s) are green whileNAGE’s FA Score has 1 green FA rating(s).

  • ADMA’s FA Score: 2 green, 3 red.
  • NAGE’s FA Score: 1 green, 4 red.
According to our system of comparison, ADMA is a better buy in the long-term than NAGE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADMA’s TA Score shows that 2 TA indicator(s) are bullish while NAGE’s TA Score has 5 bullish TA indicator(s).

  • ADMA’s TA Score: 2 bullish, 7 bearish.
  • NAGE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NAGE is a better buy in the short-term than ADMA.

Price Growth

ADMA (@Biotechnology) experienced а -2.26% price change this week, while NAGE (@Biotechnology) price change was -4.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.13%. For the same industry, the average monthly price growth was +10.99%, and the average quarterly price growth was +33.00%.

Reported Earning Dates

ADMA is expected to report earnings on Nov 05, 2025.

NAGE is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADMA($4.03B) has a higher market cap than NAGE($750M). NAGE has higher P/E ratio than ADMA: NAGE (42.77) vs ADMA (19.85). NAGE YTD gains are higher at: 77.380 vs. ADMA (-1.633). ADMA has higher annual earnings (EBITDA): 163M vs. NAGE (18.1M). ADMA has more cash in the bank: 90.3M vs. NAGE (60.3M). NAGE has less debt than ADMA: NAGE (3.29M) vs ADMA (83.8M). ADMA has higher revenues than NAGE: ADMA (474M) vs NAGE (116M).
ADMANAGEADMA / NAGE
Capitalization4.03B750M537%
EBITDA163M18.1M901%
Gain YTD-1.63377.380-2%
P/E Ratio19.8542.7746%
Revenue474M116M409%
Total Cash90.3M60.3M150%
Total Debt83.8M3.29M2,546%
FUNDAMENTALS RATINGS
ADMA vs NAGE: Fundamental Ratings
ADMA
NAGE
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
2678
SMR RATING
1..100
1625
PRICE GROWTH RATING
1..100
6442
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADMA's Valuation (69) in the Biotechnology industry is in the same range as NAGE (76) in the Chemicals Specialty industry. This means that ADMA’s stock grew similarly to NAGE’s over the last 12 months.

ADMA's Profit vs Risk Rating (26) in the Biotechnology industry is somewhat better than the same rating for NAGE (78) in the Chemicals Specialty industry. This means that ADMA’s stock grew somewhat faster than NAGE’s over the last 12 months.

ADMA's SMR Rating (16) in the Biotechnology industry is in the same range as NAGE (25) in the Chemicals Specialty industry. This means that ADMA’s stock grew similarly to NAGE’s over the last 12 months.

NAGE's Price Growth Rating (42) in the Chemicals Specialty industry is in the same range as ADMA (64) in the Biotechnology industry. This means that NAGE’s stock grew similarly to ADMA’s over the last 12 months.

NAGE's P/E Growth Rating (100) in the Chemicals Specialty industry is in the same range as ADMA (100) in the Biotechnology industry. This means that NAGE’s stock grew similarly to ADMA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADMANAGE
RSI
ODDS (%)
Bearish Trend 4 days ago
67%
Bullish Trend 5 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
67%
Bullish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 12 days ago
88%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
75%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
73%
Bullish Trend 4 days ago
74%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DSCLX18.160.10
+0.55%
DFA International Social Cor Eq Instl
RVPIX8.930.01
+0.11%
Royce Smaller-Companies Growth Instl
LVAQX19.870.01
+0.05%
LSV Small Cap Value Investor
AMRGX7.31N/A
N/A
American Growth One D
GTEYX49.16-0.08
-0.16%
Gateway Y

ADMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADMA has been loosely correlated with IMTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ADMA jumps, then IMTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMA
1D Price
Change %
ADMA100%
-0.21%
IMTX - ADMA
41%
Loosely correlated
+9.44%
IRON - ADMA
40%
Loosely correlated
+0.95%
SYRE - ADMA
39%
Loosely correlated
+0.06%
CPRX - ADMA
39%
Loosely correlated
+2.47%
IMNM - ADMA
39%
Loosely correlated
+7.35%
More

NAGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAGE has been loosely correlated with IRON. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NAGE jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAGE
1D Price
Change %
NAGE100%
+0.97%
IRON - NAGE
45%
Loosely correlated
+0.95%
MDGL - NAGE
45%
Loosely correlated
+0.39%
EPRX - NAGE
34%
Loosely correlated
+0.56%
ADMA - NAGE
32%
Poorly correlated
-0.21%
VIR - NAGE
31%
Poorly correlated
+2.53%
More